• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Merck

Merck

Merck & Co Inc MRK

Last Price$54.84Day Change (%)-1.61%
Open Price$55.64Day Change ($)-0.90
Day Range54.56–55.6452-Week Range45.69–61.70

As of Fri 4/29/2016 6:27:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Merck Announces Results From Phase 3 Studies of ZEPATIER™ (Elbasvir and Grazoprevir) in Chronic Hepatitis C Patient Populations at The International Liver Congress™

    Merck Announces Results From Phase 3 Studies of ZEPATIER™ (Elbasvir and Grazoprevir) in Chronic Hepatitis C Patient Populations at The International Liver Congress™

  2. Merck ’s ZEPATIER™ (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial

    Merck ’s ZEPATIER™ (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial

  3. ImmunoGen Reports Third Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update

    ImmunoGen Reports Third Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update

  4. Global Hypertension Drugs Market 2016-2020 - Key Vendors are Actelion, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo Company, Novartis AG & Sanofi SA - Research and Markets

    Global Hypertension Drugs Market 2016-2020 - Key Vendors are Actelion, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo Company, Novartis AG & Sanofi SA - Research and Markets

  5. Global Human Vaccine Market Growth 11.69% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: GlaxoSmithKline, Merck , Pfizer - Research and Markets

    Global Human Vaccine Market Growth 11.69% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: GlaxoSmithKline, Merck , Pfizer - Research and Markets

  6. US Biosimilars Market Report 2016 - Analysis, Technologies & Forecasts - Key Vendors: Amgen, Celltrion, Eli Lilly - Research and Markets

    US Biosimilars Market Report 2016 - Analysis, Technologies & Forecasts - Key Vendors: Amgen, Celltrion, Eli Lilly - Research and Markets

  7. Bayer Posts 13% Jump in Net Profit

    Bayer Posts 13% Jump in Net Profit

  8. Biogen Reports First Quarter 2016 Revenues of $2.7 Billion

    Biogen Reports First Quarter 2016 Revenues of $2.7 Billion

  9. Global Thalassemia Pipeline Report 2016 - Research and Markets

    Global Thalassemia Pipeline Report 2016 - Research and Markets

  10. Global Polycystic Ovarian Syndrome Pipeline Review, H1 2016 - Research and Markets

    Global Polycystic Ovarian Syndrome Pipeline Review, H1 2016 - Research and Markets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.